Your search returned 9 results.

Results
	1.	Survival instantaneous log-odds ratio from empirical functions. [electronic resource] by Jung, JungAh Drane, J Wanzer Producer: 20130710 In: The international journal of biostatistics vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures. [electronic resource] by Chung, Steve Sinha, Saurabh R Shah, Aashit Stern, John M Cheng, Hailong Jung, JungAh Grinnell, Todd Blum, David Producer: 20190903 In: Epilepsy research vol. 153 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer. [electronic resource] by Bardia, Aditya Aftimos, Philippe Bihani, Teeru Anderson-Villaluz, Alfred T Jung, JungAh Conlan, Maureen G Kaklamani, Virginia G Producer: 20200409 In: Future oncology (London, England) vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures. [electronic resource] by Abou-Khalil, Bassel Klein, Pavel Shah, Aashit Ryvlin, Philippe Specchio, Luigi M Gama, Helena Rocha, Francisco Blum, David Grinnell, Todd Cheng, Hailong Jung, JungAh Producer: 20190506 In: Epilepsy research vol. 147 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies. [electronic resource] by Almhanna, Khaldoun Kalebic, Thea Cruz, Cristina Faris, Jason E Ryan, David P Jung, JungAh Wyant, Tim Fasanmade, Adedigbo A Messersmith, Wells Rodon, Jordi Producer: 20180131 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors. [electronic resource] by Falchook, Gerald S Zhou, Xiaofei Venkatakrishnan, Karthik Kurzrock, Razelle Mahalingam, Devalingam Goldman, Jonathan W Jung, JungAh Ullmann, Claudio Dansky Milch, Catherine Rosen, Lee S Sarantopoulos, John Producer: 20161213 In: Drugs in R&D vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes. [electronic resource] by Goldberg, Stuart L Fenaux, Pierre Craig, Michael D Gyan, Emmanuel Lister, John Kassis, Jeannine Pigneux, Arnaud Schiller, Gary J Jung, JungAh Jane Leonard, E Fingert, Howard Westervelt, Peter Producer: 20140728 In: Leukemia research reports vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas. [electronic resource] by Friedberg, Jonathan W Mahadevan, Daruka Cebula, Erin Persky, Daniel Lossos, Izidore Agarwal, Amit B Jung, Jungah Burack, Richard Zhou, Xiaofei Leonard, E Jane Fingert, Howard Danaee, Hadi Bernstein, Steven H Producer: 20140228 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective aurora a kinase inhibitor, in patients with advanced solid tumors. [electronic resource] by Cervantes, Andres Elez, Elena Roda, Desamparados Ecsedy, Jeffrey Macarulla, Teresa Venkatakrishnan, Karthik Roselló, Susana Andreu, Jordi Jung, Jungah Sanchis-Garcia, Juan Manuel Piera, Adelaida Blasco, Inma Maños, Laura Pérez-Fidalgo, José-Alejandro Fingert, Howard Baselga, Jose Tabernero, Josep Producer: 20130409 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)